Indonesian Wealth Fund Says Ray Dalio to Be Informal Adviser
Indonesia's Danantara said Ray Dalio will serve as an informal adviser to the wealth fund's leadership and President Prabowo Subianto.
The Bridgewater Associates founder's role as informal adviser is voluntary and unpaid, the wealth fund said in a statement on Wednesday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
36 minutes ago
- Forbes
Buy, Sell, Or Hold CAT Stock At $350?
Close-up of a Caterpillar construction vehicle with its brand logo visible, on a sunny day in Reliez ... More Valley, California, March 3, 2025. (Photo by Smith Collection/Gado/Getty Images) Caterpillar (NYSE:CAT) stock has lagged behind the S&P 500 index over the previous six months, falling by 12% in contrast to the S&P 500's 2% drop. This underachievement corresponds with low dealer inventory levels, which signal weak overall demand for Caterpillar's offerings. This subdued demand is likely attributed to the present economic environment marked by high interest rates and elevated inflation, combined with reduced price realization for the company. In spite of these challenges, we believe it is advisable to buy Caterpillar stock. While there are risks involved, we find its current valuation to be reasonable when considering these factors. Our assessment is grounded in a thorough analysis of Caterpillar's existing valuation relative to its recent operational performance and historical financial state. Our evaluation, which looks into Growth, Profitability, Financial Stability, and Downturn Resilience, suggests that the company currently displays poor operational performance and financial well-being. However, for investors seeking lower volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — having outperformed the S&P 500 and yielded returns exceeding 91% since its initiation. Additionally, refer to – RGTI Stock: What's Next After An 1,100% Rally? When evaluating what you pay per dollar of sales or profit, CAT stock appears slightly undervalued in relation to the broader market. Caterpillar's Revenues have seen a slight decrease over recent years. Caterpillar's profit margins are approximately at the median level for firms in the Trefis coverage universe. Caterpillar's balance sheet appears weak. CAT stock has experienced an impact that was somewhat worse than the benchmark S&P 500 index during certain recent downturns. Concerned about the effects of a market crash on CAT stock? Our dashboard – How Low Can Caterpillar Stock Go In A Market Crash? – provides an in-depth analysis of how the stock performed during and after previous market crashes. In conclusion, Caterpillar's performance across the outlined parameters is summarized as follows: In general, Caterpillar has performed moderately across the assessed metrics, which is evident in its present valuation. Even when we consider valuation from an adjusted earnings perspective, the stock seems to be reasonably priced. Currently, CAT stock trades at 17x trailing earnings, which is below its five-year average price-to-earnings (P/E) ratio of 19x. We anticipate that the current dip in demand will be temporary for Caterpillar. We predict revenues will shrink in the low single digits in 2025 but expect a return to mid-single-digit growth starting in the following year. Nevertheless, investors should remain cognizant of potential risks. In the face of unfavorable macroeconomic conditions, CAT stock could underperform the overall market, as it has in previous downturns. Furthermore, the existing weakness in demand may continue, particularly if interest rates stay elevated. Although CAT stock appears attractive, investing in a single stock can be perilous. Conversely, the Trefis High Quality (HQ) Portfolio, comprising 30 stocks, has a proven record of comfortably surpassing the S&P 500 over the past 4-year period. What accounts for that? As a group, HQ Portfolio stocks have generated superior returns with lower risk compared to the benchmark index; a smoother investment journey, as reflected in HQ Portfolio performance metrics.
Bloomberg
an hour ago
- Bloomberg
Gold-Mining ETFs Losing Their Shine Following Torrid 2025 Rally
Investors are exiting exchange-traded funds that track the shares of gold-mining companies, a sign that the high-flying sector's allure may be dimming even as prices for the precious metal remain strong. Gold-mining stocks have soared this year, outpacing the 24% climb in gold prices and leaving the broader S&P 500 Index in the dust as investors sought haven assets amid worries over global trade and massive government spending. The VanEck Gold Miners ETF, the largest exchange-traded fund tracking the group, is up 57% year to date.
Entrepreneur
an hour ago
- Entrepreneur
Manila-Based telehealth Startup &you Secures Pre- Seed Funding from International Investors
The company is launching with a focus on some of the most neglected and misunderstood health issues in Southeast Asia. But its broader ambition is to become the region's most seamless and trusted online healthcare platform — a market expected to surpass $22 billion by 2030, growing at a CAGR of over 18%. Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media. &you ( a health tech startup founded by entrepreneur Emil Eriksen, has raised an undisclosed amount in pre-seed funding, backed by a strategic group of early investors in a round led by New York-based VC Everywhere Ventures. "Despite a dynamic global trade environment, the macro tailwinds behind Southeast Asia and the Philippines in particular are unquestionable. We believe in rising prosperity, the incredible power of an expanding middle class, and the demand that creates for quality healthcare products. We are excited to be investing in the Philippines for the fifth time," said Scott Hartley, co-founder and managing partner, Everywhere Ventures. The company is launching with a focus on some of the most neglected and misunderstood health issues in Southeast Asia. But its broader ambition is to become the region's most seamless and trusted online healthcare platform — a market expected to surpass $22 billion by 2030, growing at a CAGR of over 18%. Rebuilding Healthcare Starts with Restoring Trust In the Philippines, trust in the healthcare system is in short supply — and for good reason. Ninety percent of people self-medicate, not by choice but out of necessity. Seven in ten rural patients travel hours just to see a specialist. Half of Filipinos can't reach a clinic within 30 minutes, and 50% of families face financial hardship just trying to access basic care. For millions, traditional healthcare is either out of reach, unaffordable, or unreliable. That's the gap &you is stepping into — not just with technology, but with a new model built around clinical credibility, licensed care, and patient trust. Tech at its core — not layered on later While a few players already exist in the space, &you believe the current offerings fall short — especially in markets like the Philippines, where patients are often left with overpriced products, clunky apps, or worse: black-market alternatives. &you offers licensed doctor consultations and FDA-compliant treatments through a streamlined digital platform — no clinic visits required. &you is developing a fully localized end-to-end system — from mobile onboarding and medical intake to prescription and nationwide delivery — built specifically for Southeast Asia's infrastructure and behavior. The platform will use advanced technology to help users assess their health and connect them with licensed local doctors to create personalized treatment plans. "We're addressing unique regional challenges such as disrupted supply chains, user- unfriendly platforms, and a significant trust deficit. Our goal is to make getting help feel as easy and safe as ordering food," said Emil Eriksen, Founder of &you. A Homegrown Model with Global Standards Behind the scenes, &you works only with FDA-compliant partners and fully-licensed doctors, ensuring that all treatments are not only accessible but also safe and fully regulated. The company emphasizes user experience and clinical credibility — not just cheaper medicine. All &you orders are handled through carefully selected partners to ensure a smooth and confidential delivery experience. Early Traction Signals Big Demand Since launching just this April, &you has already seen rapid traction, with thousands of customers in the few month, and expects to scale quickly as awareness grows. The new funding will be used to scale engineering, expand local operations, and prepare for entry into new verticals in the next 12 months. "Healthcare doesn't work here the way it should," Eriksen says. "We're fixing that — one problem, one product, and one person at a time."
